These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36515627)

  • 1. Clinical value of combining serum tumor marker detection with fecal occult blood testing in diagnosing colorectal cancer.
    Zhou H; Wang XC; Yuan BB; Lu BB
    J Physiol Pharmacol; 2022 Jun; 73(3):. PubMed ID: 36515627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.
    Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ
    Chin J Dig Dis; 2006; 7(3):170-4. PubMed ID: 16808798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum CA724 has no diagnostic value for gastrointestinal tumors.
    Cao H; Zhu L; Li L; Wang W; Niu X
    Clin Exp Med; 2023 Oct; 23(6):2433-2442. PubMed ID: 36920593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved diagnosis of colorectal cancer using combined biomarkers including Fusobacterium nucleatum, fecal occult blood, transferrin, CEA, CA19-9, gender, and age.
    Zhao R; Xia D; Chen Y; Kai Z; Ruan F; Xia C; Gong J; Wu J; Wang X
    Cancer Med; 2023 Jul; 12(13):14636-14645. PubMed ID: 37162269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of SDC2 and Septin9 combined with serum tumor markers in early diagnosis of colorectal cancer.
    Zou CS; Xie YL; Wang DX; Liu YP; Li MQ; Chen Y; Su ZL; Liu KH
    Int J Colorectal Dis; 2024 Sep; 39(1):142. PubMed ID: 39289219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of serum Metadherin mRNA expression in the diagnosis and prediction of survival in patients with colorectal cancer.
    Abdel Ghafar MT; Gharib F; Abdel-Salam S; Elkhouly RA; Elshora A; Shalaby KH; El-Guindy D; El-Rashidy MA; Soliman NA; Abu-Elenin MM; Allam AA
    Mol Biol Rep; 2020 Apr; 47(4):2509-2519. PubMed ID: 32088817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application values of detection of serum CA199, CA242 and CA50 in the diagnosis of pancreatic cancer.
    Lei XF; Jia SZ; Ye J; Qiao YL; Zhao GM; Li XH; Chang H
    J Biol Regul Homeost Agents; 2017; 31(2):383-388. PubMed ID: 28685541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum CA242, CA199, CA125, CEA, and TSGF are Biomarkers for the Efficacy and Prognosis of Cryoablation in Pancreatic Cancer Patients.
    Chen Y; Gao SG; Chen JM; Wang GP; Wang ZF; Zhou B; Jin CH; Yang YT; Feng XS
    Cell Biochem Biophys; 2015 Apr; 71(3):1287-91. PubMed ID: 25486903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Value of Serum CEA, CA24-2 and CA19-9 in Patients with Colorectal Cancer.
    Rao H; Wu H; Huang Q; Yu Z; Zhong Z
    Clin Lab; 2021 Apr; 67(4):. PubMed ID: 33865243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.
    Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z
    Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer.
    Griesenberg D; Nürnberg R; Bahlo M; Klapdor R
    Anticancer Res; 1999; 19(4A):2443-50. PubMed ID: 10470173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of multi-detector computed tomography combined with serum tumor markers in diagnosis, preoperative, and prognostic evaluation of pancreatic cancer.
    Su J; Wang Y; Shao H; You X; Li S
    World J Surg Oncol; 2022 Sep; 20(1):323. PubMed ID: 36175918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
    Zhang SY; Lin M; Zhang HB
    Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of circulating methylated Septin9 gene DNA in diagnosis and recurrence monitoring of colorectal cancer in Western China.
    Gao JJ; Wang YW; Li Y; Wang ZL; Feng A; Li N; Hui LY
    Clin Chim Acta; 2022 Dec; 537():118-126. PubMed ID: 36330944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined detection tumor markers for diagnosis and prognosis of gallbladder cancer.
    Wang YF; Feng FL; Zhao XH; Ye ZX; Zeng HP; Li Z; Jiang XQ; Peng ZH
    World J Gastroenterol; 2014 Apr; 20(14):4085-92. PubMed ID: 24744600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The diagnostic value of serum carcinoma markers, fecal K-ras and p53 gene mutation in pancreatic cancers].
    Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ
    Zhonghua Nei Ke Za Zhi; 2005 Oct; 44(10):741-4. PubMed ID: 16255879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylated Septin9 has moderate diagnostic value in colorectal cancer detection in Chinese population: a multicenter study.
    Lu DC; Zhang QF; Li L; Luo XK; Liang B; Lu YH; Hu BL; Jiang HX
    BMC Gastroenterol; 2022 May; 22(1):232. PubMed ID: 35546391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Construction of a fecal protein Luminex liquid chip detection system for early diagnosis of colorectal tumors].
    Li J; Yin L; Zhang M; Xia Y; Zuo L; Liu M; Hu J
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Nov; 43(11):1874-1880. PubMed ID: 38081604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in Diagnosis and Prognosis for Patients with Pancreatic Cancer Treated by Concurrent Chemoradiotherapy.
    Gu YL; Lan C; Pei H; Yang SN; Liu YF; Xiao LL
    Asian Pac J Cancer Prev; 2015; 16(15):6569-73. PubMed ID: 26434876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
    Ni XG; Bai XF; Mao YL; Shao YF; Wu JX; Shan Y; Wang CF; Wang J; Tian YT; Liu Q; Xu DK; Zhao P
    Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.